| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | -0.06 | 0.09 |
| mRNA | Pazopanib | FIMM | pan-cancer | AAC | -0.32 | 0.09 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | -0.2 | 0.09 |
| mRNA | Vorinostat | FIMM | pan-cancer | AAC | -0.28 | 0.09 |
| mRNA | JNJ-26854165 | GDSC1000 | pan-cancer | AAC | -0.058 | 0.09 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.09 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | 0.053 | 0.09 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.09 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | -0.054 | 0.09 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.062 | 0.09 |